Metoprolol Tartrate — brands & medicines in Pakistan
Pakistan mein Metoprolol Tartrate ke 1 brands available hain. Drug class: Beta Blocker. Neeche se koi bhi brand select karein aur uses, dosage, side effects aur price dekhein.
Quick Answer
Metoprolol Tartrate is a beta blocker used in Pakistan for High blood pressure (BP high hona), Angina pectoris (seene ka dard), Heart failure (dil kamzor hona). Available as 1 brand. Prescription required. Always confirm dose with a doctor or pharmacist.
What is Metoprolol Tartrate?
Metoprolol Tartrate is a beta blocker used in Pakistan for a range of medical conditions. Doctors and pharmacists in Pakistan recognize Metoprolol Tartrate under multiple brand names — currently 1 listed on PakVita (1 tablet). The information below is a synthesis from DRAP-registered medicine entries, BNF, and WHO Essential Medicines references.
Common indications
- High blood pressure (BP high hona)
- Angina pectoris (seene ka dard)
- Heart failure (dil kamzor hona)
- Prevention of heart attacks (heart attack se bachao)
- Irregular heartbeat (dhadkan ka masla)
- Migraine prevention (migraine ka protection)
- Hyperthyroidism symptoms (zameen ki talaash aur hyper thyroid symptoms)
- Anxiety-related heart symptoms (dil ke dard jaise anxiety)
Indication and dose vary by medical condition, age, weight, and other factors. Always confirm with a qualified doctor or pharmacist before starting.
Typical dosage
As prescribed
This is a general adult guidance pattern based on the manufacturer's label for one of the Metoprolol Tartrate brands listed below. Children, elderly patients, pregnant women, and people with kidney or liver impairment usually need different dosing — confirm with your doctor.
Side effects
Common (usually mild)
- Most people handle Merol Tablet well, but side effects can happen.
- Tiredness or fatigue
- Dizziness
- Slow heartbeat
Serious — stop and see a doctor
- Breathing issue
- Fainting
- Severe swelling
Important warnings
- Don't use Merol Tablet if you are allergic to Metoprolol or other beta-blockers
- Avoid if you have very slow heartbeat
- Avoid if you have heart block
- Avoid if you have uncontrolled heart failure
Drug class
Beta-BlockersConditions treated
Metoprolol Tartrate brands in Pakistan (1)
Click any brand to see full uses, dosage, side effects, prices, and warnings.
Frequently asked questions
What is Metoprolol Tartrate used for in Pakistan?
Metoprolol Tartrate is commonly used for High blood pressure (BP high hona), Angina pectoris (seene ka dard), Heart failure (dil kamzor hona), Prevention of heart attacks (heart attack se bachao), and other indications. It belongs to the beta blocker drug class.
What is the typical dosage of Metoprolol Tartrate?
Typical adult dosing is described by manufacturers as: "As prescribed". Always confirm dose, duration, and timing with a qualified doctor or pharmacist — dose depends on indication, weight, age, kidney/liver function, and other medications.
What are the common side effects of Metoprolol Tartrate?
Common side effects include Most people handle Merol Tablet well, but side effects can happen., Tiredness or fatigue, Dizziness, Slow heartbeat. Most are mild and resolve as the body adjusts. Stop the medicine and contact a doctor if side effects are severe, persistent, or include allergic symptoms (rash, swelling, breathing difficulty).
When should I stop Metoprolol Tartrate and see a doctor?
Stop Metoprolol Tartrate and seek urgent medical care if you experience: Breathing issue; Fainting; Severe swelling. These are serious signs that need immediate attention.
Is Metoprolol Tartrate available without a prescription in Pakistan?
Prescription required.
What brands of Metoprolol Tartrate are available in Pakistan?
1 brand of Metoprolol Tartrate is listed on PakVita: 1 tablet. Browse the brand list below and click any name for prices, dosage, and full information.
Sources
- DRAP Registered Drug Products Database — Drug Regulatory Authority of Pakistan
- British National Formulary (BNF) — BMJ Group & Pharmaceutical Press
- WHO Model List of Essential Medicines, 23rd ed. — World Health Organization